2 news items
Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress
INVA
8 May 24
.
Key Business and R&D Highlights
Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva
ARMP
INVA
4 Mar 24
related to Armata's bacteriophage development programs, Armata's ability to set up or operate R&D and manufacturing facilities, Armata's
- Prev
- 1
- Next